Navigation Links
The Effectiveness Of The Breast Cancer Drug By Pfizer

Pfizer has increased the survival rate of breast cancer patients by 63 percent with their latest drug compared to the standard regimes available . The clinical trial strengthens the case for administering the newer drug, exemestane, as a first option.// A study showed that women recovering from breast cancer lowered their chance of developing another tumor by 32 percent if they switched to exemestane after two or three years of tamoxifen treatment.

According to the research presented this week at a breast cancer conference , the median survival for patients taking exemestane was 10.9 months, compared with 6.7 months for patients on tamoxifen. About 44.2 percent of patients in the study had tumors that responded either partially or fully to exemestane , compared with 29.2 percent on tamoxifen. The difference was statistically significant. These reports have been substantiated by specialists in the field who began trying the drug in patients in 1989, well before it was approved.

Tamoxifen is sold under the brand name Nolvadex by AstraZeneca Plc and is usually taken for five years. Tamoxifen works by blocking the hormone estrogen, which can stimulate and feed the growth of breast cancer.

By contrast, exemestane was the first approved oral therapy that binds to an enzyme known as aromatase, which normally converts the hormone androgen into estrogen in postmenopausal women. The drug thereby curtails the actual supply of estrogen to the cancerous tumors that are dependent on it, rather than blocking estrogen after it is already produced. Pfizer markets exemestane under the brand name Aromasin.

Researchers say ,"These (studies) are pieces of the puzzle, and the puzzle is becoming clearer now."
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. The Effectiveness Of Screening Tests Questioned
3. The Effectiveness Of Chickenpox Vaccine Questioned
4. The Effectiveness Of Antibacterial Products In Reducing Infection
5. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
6. Effectiveness Of Prostate Cancer Test
7. Studying The Effectiveness Of Cough Syrups
8. The Effectiveness Of NSAIDs Evaluated
9. Effectiveness Of Infertility Treatments Questioned
10. Report on the Safety and Effectiveness of Melatonin supplements
11. The Effectiveness Of Inhaled Corticosteroids Studied
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
Breaking Medicine Technology: